Acumetis names Ramil Burden CEO as founder Brent Herspiegel joins board
DFW Capital Partners portfolio company Acumetis named Ramil Burden chief executive officer, effective Sept. 14, 2026. Founder Brent Herspiegel stepped down as CEO, moved to the board to support the leadership transition. Burden previously served as CEO of Optum Life Sciences, spent 17 years at GSK in senior commercial,